Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-050564

Chief Financial Officer bought 2,000 shares at $36.80 ($73,600)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Koppikar Utpal Chief Financial Officer 2018-07-27 Purchase +2,000 $36.80 $73,600 47,000 D
Open-market purchases · 2,000 sh · avg $36.80 · $73,600
Loading xslF345X03/doc4.xml…